Clarity Pharmaceuticals Ltd has released a press release.
Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Clarity Pharmaceuticals Ltd. on 6ix
In the deck
Story so far
Earlier from Clarity Pharmaceuticals
- Clarity launches $121 million equity raise
- Trading Halt
- First participant treated in the last dose escalation cohort
- Theranostic prostate cancer trial advances to multi-dose
- Additional COBRA trial data results
Later from Clarity Pharmaceuticals
- Completion of Placement and Institutional Entitlement Offer
- Despatch of Retail Entitlement Offer Booklet
- Successful Completion of Retail Entitlement Offer
- Complete response with Cu-67 SAR-bisPSMA
- Clarity strengthens Cu-64 network with new supply agreement
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals